AEAR as a novel adjuvant can enhance antigen specific immune response without obvious side effect. AEAR can be used for human and animal vaccines with a minimum of undesirable adverse effect. The enhanced adjuvant effect is mediated by promoting DC maturation via TLR4 signaling pathway.